 | • レポートコード：PMR210127 • 出版社/出版日：Persistence Market Research / 2020年11月17日 • レポート形態：英文、PDF、269ページ • 納品方法：Eメール • 産業分類：ヘルスケア |
| Single User（1名用） | ￥676,200 (USD4,900) | ▷ お問い合わせ |
| Site Licence（同一拠点内共有可） | ￥1,048,800 (USD7,600) | ▷ お問い合わせ |
| Enterprise wide（複数拠点内共有可） | ￥1,462,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Persistence Market Research社の本調査資料では、世界の獣医分子診断市場について調査し、エグゼクティブサマリー、市場概要、主要市場動向、市場状況、市場背景、価格分析・予測、製品種類別（PCRキット、INAATキット、マイクロアレイキット、DNAシーケンシングキット）分析、疾患種類別（アナプラズマ属、エールリヒア属、ニューキャッスル病、インフルエンザ、豚繁殖・呼吸障害症候群（PRRS））分析、種別（家畜、コンパニオンアニマル）分析、エンドユーザー別（獣医病院、臨床検査室、獣医研究機関）分析、地域別分析、競争分析、仮定、調査手法などを掲載しています。 ・エグゼクティブサマリー ・市場概要 ・主要市場動向 ・市場状況 ・市場背景 ・価格分析・予測 ・世界の獣医分子診断市場規模：製品種類別（PCRキット、INAATキット、マイクロアレイキット、DNAシーケンシングキット） ・世界の獣医分子診断市場規模：疾患種類別（アナプラズマ属、エールリヒア属、ニューキャッスル病、インフルエンザ、豚繁殖・呼吸障害症候群（PRRS）） ・世界の獣医分子診断市場規模：種別（家畜、コンパニオンアニマル） ・世界の獣医分子診断市場規模：エンドユーザー別（獣医病院、臨床検査室、獣医研究機関） ・世界の獣医分子診断市場規模：地域別 ・競争分析 ・仮定 ・調査手法 |
Veterinary Molecular Diagnostics Market – Scope of Report
A latest publication by Persistence Market Research (PMR) on the global veterinary molecular diagnostics market evaluates the opportunities and current market landscape, and provides detailed analysis and updates about corresponding sections affecting the global veterinary molecular diagnostics market. The study offers detailed insights on key market dynamics, which includes the drivers, restraints, trends, and opportunities in the veterinary molecular diagnostics market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2020-2030.
Important indicators for the successful growth of the veterinary molecular diagnostics market are presented in this comprehensive report, which include supply chain analysis, value chain analysis, Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR. This research study can support readers to know the demand for veterinary molecular diagnostic products and the quantitative development opportunities during the study period.
The research is beneficial for shareholders in the veterinary molecular diagnostics market, including market investors and service providers, and can help them in developing suitable business strategies to flourish in the veterinary molecular diagnostics market. The insights and wisdom presented in this PMR study can be leveraged by shareholders in the veterinary molecular diagnostics market, industry experts, investors, researchers, reporters, as well as business enthusiasts.
Market statistics as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the veterinary molecular diagnostics market are also included in the current study. Depending on potential developments in the veterinary molecular diagnostics market, substantive insights are also encountered in this report. Additionally, by virtue of the data submitted in this report, minor companies and new entrants in the veterinary molecular diagnostics industry can be aided in making suitable company choices to achieve traction in the market space.
Key Segments of Veterinary Molecular Diagnostics Market
PMR’s study on the veterinary molecular diagnostics market offers information divided into five important segments—product, disease, species, end user, and region. This report offers comprehensive data and information about the important market dynamics, and growth parameters associated with these categories.
Product:
PCR Kits
RT-PCR Kits
RAPD-PCR Kits
INAAT Kits
Microarray Kits
DNA Sequencing Kits
Disease:
Anaplasma spp.
Ehrlichia spp.
New Castle Disease
Influenza
Porcine Reproductive & Respiratory Syndrome (PRRS)
Others
Species:
Livestock Animals
Equine
Porcine
Poultry
Bovine/Cattle
Aquatic
Ovine
Companion Animals
Canine
Feline
Avian
End User:
Veterinary Hospitals
Clinical Laboratories
Veterinary Research Institutes
Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Key Questions Answered in PMR’s Veterinary Molecular Diagnostics Market Report
Which regions will continue to remain the most profitable regional markets for veterinary molecular diagnostics?
Which factors will induce a change in the demand for veterinary molecular diagnostics during the assessment period?
How will COVID-19 change the trends in the veterinary molecular diagnostics market?
How can market players capture the low-hanging opportunities in the veterinary molecular diagnostics market in developed regions?
What are the winning strategies of stakeholders in the veterinary molecular diagnostics market to upscale their position in this landscape?
What are the restraints that investors need to be aware of and tackle while investing in the veterinary molecular diagnostics market?
What are the developmental trends in veterinary molecular diagnostics sectors that will impact the market?
How can businesses in the veterinary molecular diagnostics market avail the growth opportunities in developed and emerging economies?
Veterinary Molecular Diagnostics Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the veterinary molecular diagnostics market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the veterinary molecular diagnostics market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts interviewed specialized industry experts, medical professionals using veterinary molecular diagnostics, and key executive of product manufacturing companies, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the veterinary molecular diagnostics market, and makes PMR’s projections on the growth prospects of the veterinary molecular diagnostics market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusion and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Market Context
4.1. Product Penetration
4.2. Key Regulations
4.3. Key Competition Mapping
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Increasing Urbanization and Growing Affluence in Emerging Countries
5.1.2. Growing Demand for Precise Molecular Diagnosis Coupled with Increasing Obesity Rate
5.1.3. Increasing Awareness Towards Pet Health
5.2. Forecast Factors – Relevance & Impact
5.2.1. Rise in Awareness About Diseases in Animals Worldwide
5.2.2. High Adoption of Molecular Diagnostic Kits for Veterinary Applications
5.2.3. Higher Prevalence of Chronic & Infectious Diseases in Animals
5.2.4. Increasing Strategic Collaborations Among Key Players
5.2.5. Advancements in Molecular Technology
5.2.6. Growing Acceptance of Advanced Molecular Diagnostic Techniques
5.2.7. Ease In FDA Clearance
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
5.4. COVID19 Crisis Analysis
5.4.1. Current COVID19 Statistics and Probable Future Impact
5.4.2. Current GDP Projection and Probable Impact
5.4.3. Current Economic Projection as compared to 2008 Economic analysis
5.4.4. COVID19 and Impact Analysis
5.4.4.1. Revenue By Product Type
5.4.4.2. Revenue By Disease Type
5.4.4.3. Revenue By Species Type
5.4.4.4. Revenue By End User
5.4.4.5. Revenue By Country
5.4.5. 2020 Market Scenario
5.4.6. Quarter by Quarter Forecast
5.4.7. Projected recovery Quarter
5.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030
6.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
6.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
6.2.1. Y-o-Y Growth Trend Analysis
6.2.2. Absolute $ Opportunity Analysis
7. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) By Product Type, 2015-2019
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
7.3.1. PCR Kits
7.3.1.1. RT-PCR Kits
7.3.1.2. RAPD-PCR Kits
7.3.2. INAAT Kits
7.3.3. Microarray Kits
7.3.4. DNA Sequencing Kits
7.4. Market Attractiveness Analysis By Product Type
8. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Disease Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) By Disease Type, 2015-2019
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease Type, 2020-2030
8.3.1. Anaplasma spp.
8.3.2. Ehrlichia spp.
8.3.3. New Castle Disease
8.3.4. Influenza
8.3.5. Porcine Reproductive & Respiratory Syndrome (PRRS)
8.3.6. Others
8.4. Market Attractiveness Analysis By Disease Type
9. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Species Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Species Type, 2015-2019
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Species Type, 2020-2030
9.3.1. Livestock Animals
9.3.1.1. Equine
9.3.1.2. Porcine
9.3.1.3. Poultry
9.3.1.4. Bovine/Cattle
9.3.1.5. Aquatic
9.3.1.6. Ovine
9.3.2. Companion Animals
9.3.2.1. Canine
9.3.2.2. Feline
9.3.2.3. Avian
9.4. Market Attractiveness Analysis By Species Type
10. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by End User
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030
10.3.1. Veterinary Hospitals
10.3.2. Clinical Laboratories
10.3.3. Veterinary Research Institutes
10.4. Market Attractiveness Analysis By End User
11. Global Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030, by Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018
11.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. East Asia
11.3.5. South Asia
11.3.6. Oceania
11.3.7. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
12.1. Introduction
12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
12.3.1. By Country
12.3.1.1. U.S.
12.3.1.2. Canada
12.3.2. By Product Type
12.3.3. By Disease Type
12.3.4. By Species Type
12.3.5. By End User
12.4. Market Attractiveness Analysis
12.5. Key Market Participants – Intensity Mapping
12.6. Drivers and Restraints – Impact Analysis
13. Latin America Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
13.3.1. By Country
13.3.1.1. Brazil
13.3.1.2. Mexico
13.3.1.3. Argentina
13.3.1.4. Rest of Latin America
13.3.2. By Product Type
13.3.3. By Disease Type
13.3.4. By Species Type
13.3.5. By End User
13.4. Market Attractiveness Analysis
13.5. Key Market Participants – Intensity Mapping
13.6. Drivers and Restraints – Impact Analysis
14. Europe Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
14.3.1. By Country
14.3.1.1. Germany
14.3.1.2. Italy
14.3.1.3. France
14.3.1.4. U.K.
14.3.1.5. Spain
14.3.1.6. BENELUX
14.3.1.7. Russia
14.3.1.8. Rest of Europe
14.3.2. By Product Type
14.3.3. By Disease Type
14.3.4. By Species Type
14.3.5. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants – Intensity Mapping
14.6. Drivers and Restraints – Impact Analysis
15. South Asia Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy2020-2030
15.3.1. By Country
15.3.1.1. India
15.3.1.2. Thailand
15.3.1.3. Indonesia
15.3.1.4. Malaysia
15.3.1.5. Rest of South Asia
15.3.2. By Product Type
15.3.3. By Disease Type
15.3.4. By Species Type
15.3.5. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants – Intensity Mapping
15.6. Drivers and Restraints – Impact Analysis
16. East Asia Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
16.3.1. By Country
16.3.1.1. China
16.3.1.2. Japan
16.3.1.3. South Korea
16.3.2. By Product Type
16.3.3. By Disease Type
16.3.4. By Species Type
16.3.5. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants – Intensity Mapping
16.6. Drivers and Restraints – Impact Analysis
17. Oceania Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
17.3.1. By Country
17.3.1.1. Australia
17.3.1.2. New Zealand
17.3.2. By Product Type
17.3.3. By Disease Type
17.3.4. By Species Type
17.3.5. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants – Intensity Mapping
17.6. Drivers and Restraints – Impact Analysis
18. Middle East and Africa Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2015-2019
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2020-2030
18.3.1. By Country
18.3.1.1. GCC Countries
18.3.1.2. Turkey
18.3.1.3. South Africa
18.3.1.4. Rest of Middle East and Africa
18.3.2. By Product Type
18.3.3. By Disease Type
18.3.4. By Species Type
18.3.5. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants – Intensity Mapping
18.6. Drivers and Restraints – Impact Analysis
19. Key and Emerging Countries Veterinary Molecular Diagnostics Market Analysis 2015-2019 and Forecast 2020-2030
19.1. Introduction
19.1.1. Market Value Proportion Analysis, By Key Countries
19.1.2. Global Vs. Country Growth Comparison
19.2. U.S. Veterinary Molecular Diagnostics Market Analysis
19.2.1. By Product Type
19.2.2. By Disease Type
19.2.3. By Species Type
19.2.4. By End User
19.3. Canada Veterinary Molecular Diagnostics Market Analysis
19.3.1. By Product Type
19.3.2. By Disease Type
19.3.3. By Species Type
19.3.4. By End User
19.4. Mexico Veterinary Molecular Diagnostics Market Analysis
19.4.1. By Product Type
19.4.2. By Disease Type
19.4.3. By Species Type
19.4.4. By End User
19.5. Brazil Veterinary Molecular Diagnostics Market Analysis
19.5.1. By Product Type
19.5.2. By Disease Type
19.5.3. By Species Type
19.5.4. By End User
19.6. U.K. Veterinary Molecular Diagnostics Market Analysis
19.6.1. By Product Type
19.6.2. By Disease Type
19.6.3. By Species Type
19.6.4. By End User
19.7. Germany Veterinary Molecular Diagnostics Market Analysis
19.7.1. By Product Type
19.7.2. By Disease Type
19.7.3. By Species Type
19.7.4. By End User
19.8. France Veterinary Molecular Diagnostics Market Analysis
19.8.1. By Product Type
19.8.2. By Disease Type
19.8.3. By Species Type
19.8.4. By End User
19.9. Italy Veterinary Molecular Diagnostics Market Analysis
19.9.1. By Product Type
19.9.2. By Disease Type
19.9.3. By Species Type
19.9.4. By End User
19.10. Spain Veterinary Molecular Diagnostics Market Analysis
19.10.1. By Product Type
19.10.2. By Disease Type
19.10.3. By Species Type
19.10.4. By End User
19.11. BENELUX Veterinary Molecular Diagnostics Market Analysis
19.11.1. By Product Type
19.11.2. By Disease Type
19.11.3. By Species Type
19.11.4. By End User
19.12. Russia Veterinary Molecular Diagnostics Market Analysis
19.12.1. By Product Type
19.12.2. By Disease Type
19.12.3. By Species Type
19.12.4. By End User
19.13. China Veterinary Molecular Diagnostics Market Analysis
19.13.1. By Product Type
19.13.2. By Disease Type
19.13.3. By Species Type
19.13.4. By End User
19.14. Japan Veterinary Molecular Diagnostics Market Analysis
19.14.1. By Product Type
19.14.2. By Disease Type
19.14.3. By Species Type
19.14.4. By End User
19.15. South Korea Veterinary Molecular Diagnostics Market Analysis
19.15.1. By Product Type
19.15.2. By Disease Type
19.15.3. By Species Type
19.15.4. By End User
19.16. India Veterinary Molecular Diagnostics Market Analysis
19.16.1. By Product Type
19.16.2. By Disease Type
19.16.3. By Species Type
19.16.4. By End User
19.17. ASEAN Veterinary Molecular Diagnostics Market Analysis
19.17.1. By Product Type
19.17.2. By Disease Type
19.17.3. By Species Type
19.17.4. By End User
19.18. Australia Veterinary Molecular Diagnostics Market Analysis
19.18.1. By Product Type
19.18.2. By Disease Type
19.18.3. By Species Type
19.18.4. By End User
19.19. New Zealand Veterinary Molecular Diagnostics Market Analysis
19.19.1. By Product Type
19.19.2. By Disease Type
19.19.3. By Species Type
19.19.4. By End User
19.20. GCC Countries Veterinary Molecular Diagnostics Market Analysis
19.20.1. By Product Type
19.20.2. By Disease Type
19.20.3. By Species Type
19.20.4. By End User
19.21. Turkey Veterinary Molecular Diagnostics Market Analysis
19.21.1. By Product Type
19.21.2. By Disease Type
19.21.3. By Species Type
19.21.4. By End User
19.22. South Africa Veterinary Molecular Diagnostics Market Analysis
19.22.1. By Product Type
19.22.2. By Disease Type
19.22.3. By Species Type
19.22.4. By End User
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1.1. bioMérieux SA
20.3.1.2. Overview
20.3.1.3. Product Portfolio
20.3.1.4. Profitability by Market Segments (Product/Channel/Region)
20.3.1.5. Sales Footprint
20.3.1.6. Strategy Overview
20.3.1.6.1. Marketing Strategy
20.3.1.6.2. Product Strategy
20.3.1.6.3. Channel Strategy
20.3.2. IDEXX Laboratories, Inc.
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Profitability by Market Segments (Product/Channel/Region)
20.3.2.4. Sales Footprint
20.3.2.5. Strategy Overview
20.3.2.5.1. Marketing Strategy
20.3.2.5.2. Product Strategy
20.3.2.5.3. Channel Strategy
20.3.3. Thermo Fisher Scientific Inc.
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Profitability by Market Segments (Product/Channel/Region)
20.3.3.4. Sales Footprint
20.3.3.5. Strategy Overview
20.3.3.5.1. Marketing Strategy
20.3.3.5.2. Product Strategy
20.3.3.5.3. Channel Strategy
20.3.4. Qiagen N.V.
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Profitability by Market Segments (Product/Channel/Region)
20.3.4.4. Sales Footprint
20.3.4.5. Strategy Overview
20.3.4.5.1. Marketing Strategy
20.3.4.5.2. Product Strategy
20.3.4.5.3. Channel Strategy
20.3.5. Neogen Corporation
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Profitability by Market Segments (Product/Channel/Region)
20.3.5.4. Sales Footprint
20.3.5.5. Strategy Overview
20.3.5.5.1. Marketing Strategy
20.3.5.5.2. Product Strategy
20.3.5.5.3. Channel Strategy
20.3.6. ID.Vet
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Profitability by Market Segments (Product/Channel/Region)
20.3.6.4. Sales Footprint
20.3.6.5. Strategy Overview
20.3.6.5.1. Marketing Strategy
20.3.6.5.2. Product Strategy
20.3.6.5.3. Channel Strategy
20.3.7. INDICAL BIOSCIENCE GmbH
20.3.7.1. Overview
20.3.7.2. Product Portfolio
20.3.7.3. Profitability by Market Segments (Product/Channel/Region)
20.3.7.4. Sales Footprint
20.3.7.5. Strategy Overview
20.3.7.5.1. Marketing Strategy
20.3.7.5.2. Product Strategy
20.3.7.5.3. Channel Strategy
20.3.8. Veterinary Molecular Diagnostics, Inc.
20.3.8.1. Overview
20.3.8.2. Product Portfolio
20.3.8.3. Profitability by Market Segments (Product/Channel/Region)
20.3.8.4. Sales Footprint
20.3.8.5. Strategy Overview
20.3.8.5.1. Marketing Strategy
20.3.8.5.2. Product Strategy
20.3.8.5.3. Channel Strategy
21. Assumptions and Acronyms Used
22. Research Methodology
Table 01: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product TypeTable 02: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 03: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species
Table 04: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013–2017 and Forecast 2020–2030, By End User
Table 05: Global Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2013–2017 and Forecast 2020–2030, By Region
Table 06: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 07: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product
Table 08: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 09: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species
Table 10: North America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 11: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 12: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type
Table 13: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 14: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species type
Table 15: Latin America Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 16: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 17: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type
Table 18: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 19: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species Type
Table 20: Europe Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 21: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 22: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type
Table 23: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 24: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species Type
Table 25: South Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 26: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 27: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type
Table 28: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 29: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species Type
Table 30: East Asia Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 31: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 32: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type
Table 33: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 34: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species Type
Table 35: Oceania Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User
Table 36: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Country
Table 37: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Product Type
Table 38: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Disease Type
Table 39: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By Species Type
Table 40: MEA Veterinary Molecular Diagnostics Market size (US$ Mn) Analysis 2015–2019 and Forecast 2020–2030, By End User